- Home
- IMCC vs ADXN Comparison
IMCC vs ADXN Comparison
Compare IMCC & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- ADXN
- Stock Information
- Founded
- IMCC 1980
- ADXN 2002
- Country
- IMCC Israel
- ADXN Switzerland
- Employees
- IMCC N/A
- ADXN N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- ADXN Health Care
- Exchange
- IMCC Nasdaq
- ADXN Nasdaq
- Market Cap
- IMCC 5.0M
- ADXN 11.3M
- IPO Year
- IMCC N/A
- ADXN N/A
- Fundamental
- Price
- IMCC $2.23
- ADXN $11.26
- Analyst Decision
- IMCC
- ADXN Strong Buy
- Analyst Count
- IMCC 0
- ADXN 1
- Target Price
- IMCC N/A
- ADXN $30.00
- AVG Volume (30 Days)
- IMCC 11.8K
- ADXN 24.7K
- Earning Date
- IMCC 11-11-2024
- ADXN 11-11-2024
- Dividend Yield
- IMCC N/A
- ADXN N/A
- EPS Growth
- IMCC N/A
- ADXN N/A
- EPS
- IMCC N/A
- ADXN 0.05
- Revenue
- IMCC $36,445,402.00
- ADXN $960,641.00
- Revenue This Year
- IMCC $22.59
- ADXN N/A
- Revenue Next Year
- IMCC $20.53
- ADXN N/A
- P/E Ratio
- IMCC N/A
- ADXN $1.87
- Revenue Growth
- IMCC N/A
- ADXN N/A
- 52 Week Low
- IMCC $1.13
- ADXN $5.00
- 52 Week High
- IMCC $8.10
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- IMCC 41.06
- ADXN 64.36
- Support Level
- IMCC $2.02
- ADXN $10.04
- Resistance Level
- IMCC $2.15
- ADXN $10.81
- Average True Range (ATR)
- IMCC 0.14
- ADXN 0.63
- MACD
- IMCC -0.01
- ADXN 0.08
- Stochastic Oscillator
- IMCC 19.15
- ADXN 86.17
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.